Adawi Kamal
CIK 0001788393
Chief Financial Officer
Filings
10
Latest Jan 16, 2026
Issuers covered
2
Showing
10 of 10
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 80% | +9.8% | +11.0% | +18.4% | -1.3% |
| 90 days | 5 | 20% | -1.9% | -3.7% | +31.3% | -27.5% |
| 180 days | 5 | 0% | -27.0% | -19.4% | 0.0% | -52.6% |
| 365 days | 5 | 40% | -48.2% | -58.4% | +26.7% | -165.2% |
Issuers
Companies where Adawi Kamal has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XGN | Exagen Inc. | 8 | Mar 6, 2024 |
| FATE | Fate Therapeutics Inc | 2 | Jan 16, 2026 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|